Thalidomide was first introduced in the
1950s as a sedative. Because it was deemed to be so safe, it was prescribed to pregnant women to combat the nausea and insomnia
associated with morning sickness. Women who took the drug in early pregnancy gave birth to children with severe birth defects
such as missing or shortened limbs.
Shortly after the link between Thalidomide and birth defects was proven it was banned from use world-wide.
New applicable possibilities for that
The Drug Which Is Generating Light
In 1964, Prof. Dr. Jacob Sheskin, a doctor at Hadassah University Hospital in Jerusalem used Thalidomide
to provide some relief to a suffering man patient with leprosy who was hospitalized at
Hansen's Disease Hospital in Jerusalem. Professor Sheskin have seen that patient
great suffering thought that the drug Thalidomide would act as a sedative and help the patient to sleep.
The effects were extremely positive. Within three days the leprosy had gone and skin lesions healed. When the patient stopped
taking the Thalidomide all the lesions reappeared.
It seemed that Thalidomide would act as a suppresser, throwing the disease into retreat, although it could not actually
eradicate the illness entirely from the patient.
credit is that he made the association between the patient’s dramatic improvement and thalidomide. He had to contact
Muckter to obtain thalidomide for a larger study because this drug was banned and forbidden.
Eventually, Dr. Sheskin, after a large and profound research, came to the conclusion that thalidomide is fighting against
the autoimmune reaction of the body. He concluded from the research he made that this drug can be useful in psoriasis,
cancer and AIDS too.
The World Health Organization (WHO) confirmed a total remission of the disease in 99% of thousands of lepers treated by
him in 52 countries.
Incredibly, Thalidomide staged a comeback, as mentioned before, Dr. Sheskin, discovered the
drug had a radical effect on some of the painful symptoms of leprosy the erythema nodosum leprosum.
Professor Sheskin after a wide and deep research claimed that
this drug can help in most of the diseases that is needed to
prevents formation of new blood vessels,diseases in wich is needed to reduce inflammation
or immunology problems are involved, that is: psoriasis, sarcoidosis,
lupus, Behcet's syndrome, AIDS and cancers.
During the early 1990's he began a research to this direction
with scientist in Europe and USA.
Profrssor Dr. Sheskin Jacob deceased at the date: 17/04/1999